Association of SOD1 rs36232792 with opioid use disorder and a novel PCR-RFLP method for SOD2 rs5746136
- PMID: 40235344
- PMCID: PMC12164389
- DOI: 10.1080/14622416.2025.2490467
Association of SOD1 rs36232792 with opioid use disorder and a novel PCR-RFLP method for SOD2 rs5746136
Abstract
Aim: The aim of this study is to find out the effect of SOD1 rs36232792 and SOD2 rs5746136 on the risk of opioid use disorder (OUD).
Methods: Individuals with OUD (n = 101) and controls (n = 104) were included. SOD1 rs36232792 was genotyped by PCR. A novel PCR-RFLP method for SOD2 rs5746136 was optimized.
Results: A significant difference was observed between individuals with OUD and controls in view of the frequency of 'Ins/Del+Del/Del' genotypes of the SOD1 rs36232792 (p = 0.049), but not for SOD2 rs5746136 (p = 0.254). The intensity of anxiety and depressive symptoms was significantly higher in individuals with OUD compared to controls (p = 0.001).
Conclusion: The SOD1 rs36232792 polymorphism could contribute to the risk of OUD in a Turkish population. A novel PCR-RFLP method for SOD2 rs5746136 confirmed by sequencing can be used in a research laboratory without advanced equipment.
Keywords: Opioid use disorder; SOD1; SOD2; antioxidant enzymes; interindividual variability.
Conflict of interest statement
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.
Similar articles
-
How Is Preoperative Opioid Use Associated With Readmissions and Outcomes in Lower Extremity Trauma?Clin Orthop Relat Res. 2025 May 1;483(5):918-927. doi: 10.1097/CORR.0000000000003346. Epub 2024 Dec 20. Clin Orthop Relat Res. 2025. PMID: 39787379
-
Effectiveness of methadone versus buprenorphine in the treatment of opioid use disorder: secondary analyses of prospective cohort study data.BMJ Open. 2025 Jun 17;15(6):e095645. doi: 10.1136/bmjopen-2024-095645. BMJ Open. 2025. PMID: 40527567 Free PMC article.
-
miR-146a rs2910164 (G/C) variant may predict morbid obesity risk in adults.Nucleosides Nucleotides Nucleic Acids. 2025;44(8):653-663. doi: 10.1080/15257770.2024.2393323. Epub 2024 Aug 20. Nucleosides Nucleotides Nucleic Acids. 2025. PMID: 39162052
-
Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.Health Technol Assess. 2007 Feb;11(6):iii-iv, 1-85. doi: 10.3310/hta11060. Health Technol Assess. 2007. PMID: 17280624
-
A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder.Addict Sci Clin Pract. 2021 Nov 27;16(1):70. doi: 10.1186/s13722-021-00278-y. Addict Sci Clin Pract. 2021. PMID: 34838141 Free PMC article.
References
-
- Evren EC. Bağımlılığın Moleküler ve Hücresel Temeli. Klinik Psikofarmakoloji Bülteni. 1998;8(1):47–50.
-
- Azadfard M, Huecker MR, Leaming JM. Opioid addiction. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing ; 2023. https://www.ncbi.nlm.nih.gov/books/NBK448203/ - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous